Product Evaluations
The Place to get world-class Management, Marketing and Forecasting
New Product Evaluations / Assessments / Valuations
Key components of our new product evaluations include:
Peak sales potential
10 Year sales & profit forecasts including NPV, DCF & IRR
Identification of value drivers and sensitivity analysis
Development of the Comparative Performance Profile (CPP)
Determining the “must have” attributes for commercial success
Determining the “relative competitiveness” of a product
Identification of “analogue” products & markets
Development of decision trees to develop road maps for development plans
Identification of the “point of no return”
Risk Assessment and Monte Carlo Simulation
Guidelines for New Product Evaluations
1.1 Critical Success Factors
1.2 Market Definition
1.3 Project Rationale
1.4 Key Assumptions
1.5 Resource Requirements
1.6 Project Objectives
1.7 Opportunities and Risks
1.8 Critical Success Factors (CSF’s)
2.1 Medical Rationale
2.2 Field of therapy: other treatments approaches
2.3 Active ingredient: description, mode of action
2.4 Expected (precise) indications for use in SPC/GPI
2.5 Therapeutic risk / benefit ratio analysis
2.6 Differentiation from other products
2.7 Health economics
2.8 Availability
2.9 Commercial Rationale
3.1 Legal Status/ Intellectual Property
3.2 Pharmaceutical Development
3.3 Clinical Development
3.4 Regulatory Situation
3.5 Materials Management
3.6 Manufacturing
3.7 Cost of Goods
4.1 Product Owner
4.2 Contractual Arrangements
4.3 IP position
5.1 Market definition
5.2 Definition of competition
5.3 Quantitative market analysis
5.4 Qualitative market analysis
5.5 Major competitor evaluation
5.6 Analysis of new product launches
6.1 Assumptions
6.2 Market Potential Projections
Therapeutic class sales, Patient days etc.
7.1 Political / Governmental
7.2 Cultural Habits
7.3 New Competition
7.4 Other
8.1 Set of Assumptions
8.2 Product Strategy
8.3 Adjusted Market Projections
8.4 Product Sales & Expense Forecasts
8.5 Other Data
9.1 10 Year Product Income Statement (P.I.S.)
9.2 Financial Analysis
NPV, DCF, IRR etc.
10.1 Accelerators / Decelerators
10.2 Critical Success Factors & Contingency Plan
10.3 Decision Criteria
